Reactivated DRP1 Enables Resistance to MEK Inhibitors in Pancreatic Cancer Cells
Pancreatic cancer remains notoriously difficult to treat, and targeted therapies often fall short when tumor cells activate escape routes. A ...
Pancreatic cancer remains notoriously difficult to treat, and targeted therapies often fall short when tumor cells activate escape routes. A ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine